Answers are grounded in this paper and cite their sources.
Our study shows the value of systematic genome sequencing in understanding the phenotypic heterogeneity of common diseases and identifying failure to diagnose rare diseases and highlights the benefits of deep molecular phenotyping in clinical trials and patient care. (Funded by AbbVie and NIHR Cambridge Biomedical Research Centre.).
No takes yet. Share an insight, caveat, or question.
Rahimov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: